Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)

DOI: 10.1186/1471-2474-14-s1-a10

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text